Development Level

Tbio 3 | 10,625
Tclin 3 | 602

IMPC Term

abnormal behavior 1 | 226
abnormal gait 1 | 51
abnormal vocalization 1 | 21
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating chloride... 1 | 32
decreased lean body mass 1 | 195
decreased leukocyte cell numbe... 1 | 54
decreased lumbar vertebrae num... 1 | 62
decreased spleen weight 1 | 13
enlarged liver 1 | 3
hypoactivity 1 | 89
increased circulating HDL chol... 1 | 63
increased circulating alanine ... 1 | 11
increased circulating alkaline... 1 | 119
increased circulating aspartat... 1 | 17
increased circulating calcium ... 1 | 32
increased circulating choleste... 1 | 53
increased circulating fructosa... 1 | 11
increased circulating glucose ... 1 | 16
increased circulating iron lev... 1 | 25
increased circulating phosphat... 1 | 24
increased circulating potassiu... 1 | 31
increased circulating serum al... 1 | 25
increased circulating total pr... 1 | 20
increased hematocrit 1 | 36
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased sacral vertebrae num... 1 | 62
increased total body fat amoun... 1 | 57
lethargy 1 | 5
small seminal vesicle 1 | 6
thrombocytopenia 1 | 46
tremors 1 | 34

Disease

ovarian cancer 6 | 8,484
psoriasis 6 | 6,685
Cancer 5 | 2,346
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
invasive ductal carcinoma 4 | 2,950
pancreatic cancer 4 | 2,300
ulcerative colitis 4 | 2,087
Atopic dermatitis 3 | 944
Breast cancer 3 | 3,094
Diabetes Mellitus, Non-Insulin-Dependent 3 | 157
Hyperglycemia 3 | 120
Hypertension 3 | 287
Mammary Neoplasms 3 | 410
Obesity 3 | 616
atypical teratoid / rhabdoid tumor 3 | 4,369
cutaneous lupus erythematosus 3 | 1,056
cystic fibrosis 3 | 1,665
diabetes mellitus 3 | 1,663
lung adenocarcinoma 3 | 2,713
lung cancer 3 | 4,466
pituitary cancer 3 | 1,972
Alzheimer's disease 2 | 644
Anorexia nervosa 2 | 59
Arthritis 2 | 248
Arthritis, Experimental 2 | 39
Asthma 2 | 349
Atherosclerosis 2 | 275
Carcinoma 2 | 2,147
Cardiovascular system disease 2 | 194
Cataract 2 | 104
Cerebrovascular disease 2 | 231
Colonic Neoplasms 2 | 126
Coronary artery disease 2 | 240
Diabetes Mellitus, Experimental 2 | 106
Fatty liver disease 2 | 84
Female infertility 2 | 28
Gastric ulcer 2 | 34
Gestational Diabetes 2 | 17
Gout 2 | 93
Heart disease 2 | 279
Hyperinsulinism 2 | 63
Hyperphagia 2 | 4
Hypertensive disease 2 | 193
Hypogonadism 2 | 70
Infertility 2 | 163
Inflammation 2 | 109
Insulin Resistance 2 | 48
Kidney disease 2 | 396
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Metabolic syndrome X 2 | 155
Obesity, Morbid 2 | 6
Polycystic Ovary Syndrome 2 | 332
Prostatic Neoplasms 2 | 471
Proteinuria 2 | 63
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
breast carcinoma 2 | 1,614
chronic rhinosinusitis 2 | 512
ductal carcinoma in situ 2 | 1,745
glioblastoma 2 | 5,572
group 3 medulloblastoma 2 | 2,254
hepatocellular carcinoma 2 | 532
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung carcinoma 2 | 2,844
mucosa-associated lymphoid tissue lymphoma 2 | 480
non-small cell lung cancer 2 | 2,798
osteosarcoma 2 | 7,933
pancreatic carcinoma 2 | 567
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pilocytic astrocytoma 2 | 3,086
primary Sjogren syndrome 2 | 789
sarcoidosis 2 | 358
spina bifida 2 | 1,064
tuberculosis 2 | 1,557
ATHEROSCLEROSIS, SUSCEPTIBILITY TO 1 | 3
Brain edema 1 | 26
Bronchitis, Chronic 1 | 9
Bulimia nervosa 1 | 15
Carcinoma, Pancreatic Ductal 1 | 19
Cerebral Hemorrhage 1 | 27
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diarrhea 1 | 155
Head and Neck Neoplasms 1 | 23
Heart Diseases 1 | 42
Hemangioma 1 | 35
Hemangiosarcoma 1 | 18
Hyperthyroidism 1 | 50
Klinefelter's syndrome 1 | 59
Malignant tumor of peritoneum 1 | 4
Mood disorder 1 | 10
Myocardial Reperfusion Injury 1 | 34
Neoplasms, Experimental 1 | 33
Obstructive sleep apnea 1 | 28
Osteochondrodysplasias 1 | 15
Polyneuropathy 1 | 30
Precancerous Conditions 1 | 69
Retinopathy of prematurity 1 | 21
Uveitis 1 | 103

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 4 | 11,971
Kinase 2 | 634

Grant Application

5R01CA095004-10 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Leptin receptor LEPR Tclin Non-IDG -2.98449 751.7 530
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796
Ephrin-A1 EFNA1 Tbio Kinase -1.97284 94.5 212
Ephrin type-A receptor 2 EPHA2 Tclin Kinase -2.84710 785.1 704